Rampart Bioscience is evolving a new class of medicines for patients with genetically driven diseases. We integrate capabilities from a variety of key scientific disciplines — including gene delivery, protein sciences and clinical translation — to leap beyond the limitations of current gene therapies.

Powered by our novel non-viral DNA delivery system, we are on a path to achieve higher standards for potency, durability, redosability and safety. Together, we are working to reshape the treatment landscape for people in dire need of better options.

Biotechnology

Life Sciences

Therapeutics

Rampart Bioscience

Rampart Bioscience's headquarters in Monrovia, CA, United States

Jeffrey Bartlett

William Hallows

Gregory E.

Mario Mata Corral

Alexandra Ciminera Stanton

Annika Holquist

Penney McWilliams-Koeppen

Martha Velasco

Rampart Bioscience

Org chart

Teams

Offices

Rampart Bioscience

Org chart

Teams

Offices

Related companies